drug

luliconazole

Marketedupdated 2mo ago

by Bausch Health US LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Sep 6, 2033

~7.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Apr 28, 2034formulationUS 8980931
Sep 6, 2033compositionUS 9012484
Sep 6, 2033compositionUS 9199977
Sep 6, 2033compositionUS 9453006

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying luliconazole

phase3A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphomaactive not recruitingn=478